Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect on pharmacokinetics of once-weekly brexpiprazole in schizophrenia
jRCT2071230059Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of brexpiprazole in schizophrenia (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoints: Cmax of brexpiprazole (fed vs fasting), AUCinfinity of brexpiprazole (fed vs fasting) and 1 more. Started Oct 2023; status: completed.
02
Drugs
brexpiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2071230059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230059.